Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council Co-operative study of rifampicin plus ethambutol in daily and intermittent regimens. Correlation between the presence of rifampicin-dependent antibodies and the clinical data.
D000917:Antibody Formation / Q000187:drug effects*; D006801:Humans; D012293:Rifampin / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000276:immunology
D012293:Rifampin